CG MED EQUIP.
838810
BEOKA
870199
Shenzhen Bromake New Material
301387
4
Zhejiang Hongchang Electrical Technology
301008
5
Wuhan Lincontrol Automotive Electronics Co., Ltd.
688667
CN Stock MarketDetailed Quotes
688617 APT Medical Inc.
- 416.12
- -7.83-1.85%
Market Closed Apr 30 15:00 CST
40.40BMarket Cap56.41P/E (TTM)
431.81High416.00Low8.30KlotVolume421.23Open423.95Pre Close350.78MTurnover0.86%Turnover Ratio60.01P/E (Static)97.08MShares480.0052wk High14.96P/B40.40BFloat Cap292.5452wk Low508.74Limit Up97.08MShs Float480.00Historical High339.16Limit Down3.73%Amplitude94.85Historical Low1.38Dividend TTM422.47Avg Price4.17KlotAsk0.33%Div YieldTTM100Lot Size3.58KlotBid
APT Medical Inc. News
We Ran A Stock Scan For Earnings Growth And APT Medical (SHSE:688617) Passed With Ease
The Deputy General Manager of APT Medical Inc. (688617.SH), Han Yonggui, completed a Shareholding of 0.0299 million shares.
APT Medical Inc. (688617.SH) announced that the company's vice president Han Yonggui has reduced his shareholding through centralized bidding Trade...
Direct coverage of the Star medical instruments industry collective Earnings Conference: Multiple companies are laying out AI medical Business, and key segments in innovation fields may accelerate the development of domestic production.
① Attending companies believe that tariff policies will bring some cost pressures and market challenges to enterprises, but at the same time, it has accelerated the localization process in relevant fields; ② Some attending companies disclosed the latest developments in their Business during the earnings briefing and the planning for related lines by 2025.
APT Medical's 2024 Profit Rises 26%, Operating Income Climbs 25%; Shares Drop 4%
Huitai Healthcare: 2024 Annual Report Summary
Huitai Healthcare: First Quarter Report 2025
Huitai Healthcare: 2024 Annual Report
2024 ANNUAL REPORT
2024 Annual Report Summary
2025 First Quarter Report
Gelonghui Announcement Selected: Sunyard Technology: The cross-border payment business involved by the company is not its main product; APT Medical Inc.: In 2024, the Net income is projected to grow by 26.08% year-on-year, planning a 10 to 4.5 bonus with
【Hotspot Tracking】Gansu Guofang Industry & Trade (601086.SH): The company's stock has seen a short-term increase significantly higher than the Industry Index, with substantial irrational speculation and very high trading risks. Sunyard Technology (600571.SH): The cross-border payment business involved is not the company's main product. Anhui Anli Material Technology (300218.SZ): The overall tariff risk is controllable. 【Project Investment】3onedata Co., Ltd. (688618.SH): Plans to jointly invest with Jiuzhao Investment in the Wuhe Jiuzhao 3onedata Fund. Bi Yi Co., Ltd. (603215.SH): Plans to jointly invest with the controlling Shareholder to establish a private equity fund. Hui Green Ecology (001267.
Express News | Apt Medical Says 2024 Net Profit up 26.1% Y/Y
Express News | Apt Medical Q1 Net Profit up 30.7% Y/Y
APT Medical Inc. (688617.SH): In 2024, net income is expected to grow by 26.08% year-on-year, with a proposal for a 10-for-4.5 stock split and a dividend of 17.50 yuan.
On April 22, Gelonghui reported that APT Medical Inc. (688617.SH) announced its 2024 annual report, achieving revenue of 2.066 billion yuan during the reporting period, a year-on-year increase of 25.18%; net income attributable to shareholders of the listed company was 0.673 billion yuan, up 26.08% year-on-year; basic EPS was 6.96 yuan. A cash dividend of 17.50 yuan (including tax) is proposed to be distributed to all shareholders for every 10 shares, and the company plans to convert 4.5 shares for every 10 shares from capital reserves, without issuing bonus shares.
Shareholders Would Enjoy A Repeat Of APT Medical's (SHSE:688617) Recent Growth In Returns
APT Medical Inc. (688617.SH): Vice General Manager Han Yonggui plans to reduce his shareholding by no more than 0.03 million shares.
On April 3, Glorious Securities reported that APT Medical Inc. (688617.SH) announced that it had recently received a notice from Mr. Han Yonggui, the company's deputy general manager, regarding the shareholding reduction plan. The reduction entity plans to reduce its holdings by no more than 30,000 shares, which is no more than 0.0309% of the company's total share capital. For reductions made through centralized bidding, the total number of shares reduced within any 90 consecutive calendar days will not exceed 1% of the company's total share capital, with the reduction period set for three months starting from the 15th trading day after the announcement date; for reductions made through block trading, in任
APT Medical Inc. (688617.SH): DeepSeek has not yet been deployed.
On March 26, Glenwood reported that APT Medical Inc. (688617.SH) stated on the interactive platform that as of now, the company has not deployed DeepSeek. The company will continue to pay attention to the development of AI technology and explore its application in Business.
Risks To Shareholder Returns Are Elevated At These Prices For APT Medical Inc. (SHSE:688617)
APT Medical Gets Registration Certificate for Vena Cava Filter System
APT Medical Gets Medical Device Registration for Medical Catheter Sensor